279 related articles for article (PubMed ID: 33331515)
1. Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning.
EkŞİ Z; ÇakiroĞlu M; Öz C; AralaŞmak A; Karadelİ HH; Özcan ME
Arq Neuropsiquiatr; 2020 Dec; 78(12):789-796. PubMed ID: 33331515
[TBL] [Abstract][Full Text] [Related]
2. Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis.
Kizlaitienė R; Kaubrys G; Giedraitienė N; Ramanauskas N; Dementavičienė J
Med Sci Monit; 2017 Feb; 23():588-597. PubMed ID: 28145395
[TBL] [Abstract][Full Text] [Related]
3. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
[TBL] [Abstract][Full Text] [Related]
4. Association of Cortical Lesions With Regional Glutamate, GABA,
Madsen MA; Považan M; Wiggermann V; Lundell H; Blinkenberg M; Romme Christensen J; Sellebjerg F; Siebner HR
Neurology; 2024 Jul; 103(1):e209543. PubMed ID: 38870443
[TBL] [Abstract][Full Text] [Related]
5. (1)H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings.
Sijens PE; Mostert JP; Oudkerk M; De Keyser J
Eur Radiol; 2006 Feb; 16(2):489-95. PubMed ID: 16028056
[TBL] [Abstract][Full Text] [Related]
6. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
7. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.
Adalsteinsson E; Langer-Gould A; Homer RJ; Rao A; Sullivan EV; Lima CA; Pfefferbaum A; Atlas SW
AJNR Am J Neuroradiol; 2003; 24(10):1941-5. PubMed ID: 14625214
[TBL] [Abstract][Full Text] [Related]
8. Addition of quantitative MRI to the routine clinical care of patients with multiple sclerosis-Results from the MAGNON project.
Leussink VI; Jankovic M; Groth M; Schuh K; Sauerbeck IS; Hoffmann O
Brain Behav; 2024 Jun; 14(6):e3548. PubMed ID: 38841819
[TBL] [Abstract][Full Text] [Related]
9. Olfactory Dysfunction Reflects Disease Progression in Japanese Patients with Multiple Sclerosis.
Okada K; Kakeda S; Tahara M
Intern Med; 2022 Nov; 61(21):3181-3187. PubMed ID: 35400704
[TBL] [Abstract][Full Text] [Related]
10. Relapsing-remitting and secondary-progressive multiple sclerosis patients differ in decoding others' emotions by their eyes.
Argento O; Spanò B; Serra L; Incerti CC; Bozzali M; Caltagirone C; Francia A; Fratino M; Nocentini U; Piacentini C; Quartuccio ME; Pisani V
Eur J Neurol; 2022 Feb; 29(2):505-514. PubMed ID: 34687120
[TBL] [Abstract][Full Text] [Related]
11. The role of endogenous antiradical protective system in multiple sclerosis.
Davitashvili D; Beridze M; Shakarishvili R; Kiziria M; Sanikidze T
Georgian Med News; 2012 Apr; (205):11-9. PubMed ID: 22665726
[TBL] [Abstract][Full Text] [Related]
12. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
[TBL] [Abstract][Full Text] [Related]
13. A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study.
Ziemssen T; Piani-Meier D; Bennett B; Johnson C; Tinsley K; Trigg A; Hach T; Dahlke F; Tomic D; Tolley C; Freedman MS
J Med Internet Res; 2020 Feb; 22(2):e16932. PubMed ID: 32049062
[TBL] [Abstract][Full Text] [Related]
14. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
[TBL] [Abstract][Full Text] [Related]
15. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
[TBL] [Abstract][Full Text] [Related]
16. Subtyping relapsing-remitting multiple sclerosis using structural MRI.
Zhuo Z; Li Y; Duan Y; Cao G; Zheng F; Ding J; Tian D; Wang X; Wang J; Zhang X; Li K; Zhou F; Huang M; Li Y; Li H; Zeng C; Zhang N; Sun J; Yu C; Han X; Haller S; Barkhof F; Shi F; Liu Y
J Neurol; 2021 May; 268(5):1808-1817. PubMed ID: 33387013
[TBL] [Abstract][Full Text] [Related]
17. Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
Obert D; Helms G; Sättler MB; Jung K; Kretzschmar B; Bähr M; Dechent P; Diem R; Hein K
PLoS One; 2016; 11(9):e0162583. PubMed ID: 27636543
[TBL] [Abstract][Full Text] [Related]
18. Continuous diffuse brain atrophy independent of relapse as a hallmark of multiple sclerosis beginning from relapsing-remitting stage.
Akaishi T; Fujimori J; Yokote H; Nakashima I
Clin Neurol Neurosurg; 2024 Jul; 242():108342. PubMed ID: 38772279
[TBL] [Abstract][Full Text] [Related]
19. Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: A population-based case-control study.
Sechi E; Messina S; Keegan BM; Buciuc M; Pittock SJ; Kantarci OH; Weinshenker BG; Flanagan EP
Mult Scler; 2021 Apr; 27(5):667-673. PubMed ID: 32552535
[TBL] [Abstract][Full Text] [Related]
20. Secondary progressive multiple sclerosis: a systematic review of costs and health state utilities.
Chataway J; Murphy N; Khurana V; Schofield H; Findlay J; Adlard N
Curr Med Res Opin; 2021 Jun; 37(6):995-1004. PubMed ID: 33733976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
